| Product Code: ETC6815845 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite the high concentration of top exporters, the Congo pneumococcal vaccine import market saw a significant decline in both CAGR and growth rate in 2023. The top exporters to Congo, including France, India, Belgium, Egypt, and Germany, are likely facing challenges in the market. It will be crucial for these exporters to reassess their strategies and offerings to adapt to the changing landscape and potentially regain momentum in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Congo Pneumococcal Vaccine Market Overview |
3.1 Congo Country Macro Economic Indicators |
3.2 Congo Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Congo Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Congo Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Congo Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Congo Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Congo Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Congo Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Congo Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Congo Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Government initiatives to improve access to healthcare services and vaccines |
4.2.3 Rising incidences of pneumococcal infections in Congo |
4.3 Market Restraints |
4.3.1 High cost of pneumococcal vaccines leading to affordability issues for the population |
4.3.2 Lack of adequate healthcare infrastructure in remote areas impacting vaccine distribution and administration |
5 Congo Pneumococcal Vaccine Market Trends |
6 Congo Pneumococcal Vaccine Market, By Types |
6.1 Congo Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Congo Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Congo Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Congo Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Congo Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Congo Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Congo Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Congo Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Congo Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Congo Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Congo Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Congo Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Congo Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Congo Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Congo Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Congo Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Congo Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Congo Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Congo Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Congo Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Congo Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Congo Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Congo Pneumococcal Vaccine Market Export to Major Countries |
7.2 Congo Pneumococcal Vaccine Market Imports from Major Countries |
8 Congo Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates for pneumococcal vaccines |
8.2 Number of government-funded vaccination programs targeting pneumococcal diseases |
8.3 Reduction in pneumococcal infection rates in high-risk populations |
9 Congo Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Congo Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Congo Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Congo Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Congo Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Congo Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Congo Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Congo Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Congo Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |